Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 15673T100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
RTW Investments, LP
13G
|
7.1% |
5/15/2026
Event 3/31/2026
|
|
| RTW Investments, LP | 7.1% | ||
| Roderick Wong | 7.1% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 2
|
3.3% |
5/15/2026
Event 3/31/2026
|
|
| Point72 Asset Management, L.P. | 3.3% | ||
| Point72 Capital Advisors, Inc. | 3.3% | ||
| Steven A. Cohen | 3.3% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 1
|
6.8% |
2/17/2026
Event 12/23/2025
|
|
| Point72 Asset Management, L.P. | 6.8% | ||
| Point72 Capital Advisors, Inc. | 6.8% | ||
| Steven A. Cohen | 6.8% | ||
|
Commodore Capital LP
13G
|
7.1% |
1/16/2026
Event 1/9/2026
|
|
| Commodore Capital LP | 7.1% | ||
| Commodore Capital Master LP | 7.1% | ||
| Robert Egen Atkinson | 7.1% | ||
| Michael Kramarz | 7.1% | ||
|
Venrock Healthcare Capital Partners III, L.P.
13G
|
7.1% |
1/16/2026
Event 1/9/2026
|
|
| Venrock Healthcare Capital Partners III, L.P. | 7.1% | ||
| VHCP Co-Investment Holdings III, LLC | 7.1% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 7.1% | ||
| VHCP Management III, LLC | 7.1% | ||
| VHCP Management EG, LLC | 7.1% | ||
| Nimish Shah | 7.1% | ||
| Bong Y. Koh | 7.1% | ||
|
RA Capital Management, L.P.
13G
|
9.9% |
1/16/2026
Event 1/9/2026
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
TCG Crossover GP II, LLC
13G
|
9.9% |
1/15/2026
Event 1/9/2026
|
|
| TCG Crossover GP II, LLC | 4.9% | ||
| TCG Crossover Fund II, L.P. | 4.9% | ||
| TCG Crossover GP III, LLC | 4.9% | ||
| TCG Crossover Fund III, L.P. | 4.9% | ||
| Chen Yu | 9.9% | ||
|
Deep Track Capital, LP
13G
|
7.3% |
1/15/2026
Event 1/8/2026
|
|
| Deep Track Capital, LP | 7.3% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 5.8% | ||
| David Kroin | 7.3% | ||
| Deep Track Special Opportunities Fund, LP. | 1.6% | ||
|
Point72 Asset Management, L.P.
13G
|
5.4% |
1/5/2026
Event 12/23/2025
|
|
| Point72 Asset Management, L.P. | 5.4% | ||
| Point72 Capital Advisors, Inc. | 5.4% | ||
| Steven A. Cohen | 5.4% | ||
| Bain Capital Life Sciences Opportunities III, LP 13G/A Amendment 1 | 4.1% |
11/14/2025
Event 9/30/2025
|
|
|
Casdin Capital, LLC
13G/A
Amendment 1
|
3.7% |
5/15/2025
Event 3/31/2025
|
|
| Casdin Capital, LLC | 3.7% | ||
| Eli Casdin | 3.7% | ||
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
Amendment 2
|
4.7% |
2/14/2025
Event 12/31/2024
|
|
| Venrock Healthcare Capital Partners III, L.P. | 4.7% | ||
| VHCP Co-Investment Holdings III, LLC | 4.7% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 4.7% | ||
| VHCP Management III, LLC | 4.7% | ||
| VHCP Management EG, LLC | 4.7% | ||
| Nimish Shah | 4.7% | ||
| Bong Y Koh | 4.7% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 1.06 k | $1.82 k |
| 2026 Q2 | 105 | 158 M | $389 M |
| 2026 Q1 | 74 | 139 M | $312 M |
| 2025 Q4 | 47 | 25.7 M | $25.6 M |
| 2025 Q3 | 58 | 20.3 M | $10.1 M |
| 2025 Q2 | 68 | 22.6 M | $12.6 M |
| 2025 Q1 | 72 | 29.6 M | $14.1 M |
| 2024 Q4 | 75 | 36.4 M | $36.8 M |
| 2024 Q3 | 71 | 39.7 M | $67.9 M |
| 2024 Q2 | 67 | 40.4 M | $103 M |
| 2024 Q1 | 73 | 23.6 M | $98.5 M |
| 2023 Q4 | 69 | 18.0 M | $59.8 M |
| 2023 Q3 | 58 | 18.1 M | $36.1 M |
| 2023 Q2 | 67 | 19.3 M | $61.0 M |
| 2023 Q1 | 67 | 20.0 M | $69.5 M |
| 2022 Q4 | 70 | 21.2 M | $109 M |
| 2022 Q3 | 57 | 21.1 M | $209 M |
| 2022 Q2 | 57 | 21.8 M | $183 M |
| 2022 Q1 | 53 | 22.2 M | $279 M |
| 2021 Q4 | 51 | 21.1 M | $335 M |
| 2021 Q3 | 50 | 19.8 M | $496 M |
| 2021 Q2 | 37 | 16.9 M | $491 M |